AIFinancial Timesabout 16 hours ago
MindWalk CEO Joins Absci AI Drug Discovery Panel
1 min read
MindWalk CEO Dr. Jennifer Bath will join Absci and a leading AI compute provider on a Jones AI Day panel. The discussion will focus on the future of AI drug discovery. The panel brings together executives from MindWalk, Absci, and an unnamed compute provider.
Level
Hype check
Tap to vote and see what everyone thinks.
